Complete Pathologic Response After Neoadjuvant Chemoradiotherapy for Esophageal Cancer Is Associated With Enhanced Survival

Annals of Thoracic Surgery

Volumn 87, Issue 2, 2009, Pages 392-399

  Donahue, James M ^a   Nichols, Francis C ^a   Li, Zhuo ^a   Schomas, David A ^a   Allen, Mark S ^a   Cassivi, Stephen D ^a   Jatoi, Aminah ^a   Miller, Robert C ^a   Wigle, Dennis A ^a   Shen, K Robert ^a   Deschamps, Claude ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CONTROLLED STUDY; ENDOSCOPIC ECHOGRAPHY; ESOPHAGUS CANCER; ESOPHAGUS SURGERY; FEMALE; GASTRECTOMY; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT RESPONSE;

ADENOCARCINOMA; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; CONFIDENCE INTERVALS; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PREOPERATIVE CARE; PROBABILITY; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX FACTORS; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 58249129132     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2008.11.001     Document Type: Article

References (38)

1. Cancer Facts & Figures 2007 (2007), American Cancer Society, Inc
2. Visbal A.L., Allen M.S., Miller D.L., Deschamps C., Trastek V.F., and Pairolero P.C. Ivor Lewis esophagogastrectomy for esophageal cancer. Ann Thorac Surg 71 (2001) 1803-1808
3. Jaroszewski D.E., Deschamps C., Gunderson L.L., Lanza L.A., Trastek V.F., and Pairolero P.C. Cancer of the esophagus. In: Kelly K.A., Sarr M.G., and Hinder R.A. (Eds). Mayo Clinic gastrointestinal surgery (2004), WB Saunders, Philadelphia, PA 57-73
4. Chak B., and Forastiere A.A. Neoadjuvant therapy for esophageal cancer. In: Yang C.Y., and Cameron D.E. (Eds). Current therapy in thoracic and cardiovascular surgery (2004), Mosby, Philadelphia, PA 356-360
5. Behzadi A., Nichols F.C., Cassivi S.D., Deschamps C., Allen M.S., and Pairolero P.C. Esophagogastrectomy: the influence of stapled versus hand-sewn anastomosis on outcome. J Gastrointest Surg 9 (2005) 1031-1040
6. Vigneswaran W.T., Trastek V.F., Pairolero P.C., Deschamps C., Daly R.C., and Allen M.S. Extended esophagectomy in the management of carcinoma of the upper thoracic esophagus. J Thorac Cardiovas Surg 107 (1994) 901-906
7. Vigneswaran W.T., Trastek V.F., Pairolero P.C., Deschamps C., Daly R.C., and Allen M.S. Transhiatal esophagectomy for carcinoma of the esophagus. Ann Thorac Surg 56 (1993) 838-844
8. American Joint Committee on Cancer. AJCC cancer staging handbook (2002), Springer-Verlag, New York
9. Kaplan E., and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
10. Cox D.R. Regression models and life tables (with discussion). J Royal Stat Soc Series B 34 (1972) 187-220
11. Peto R., and Peto J. Asymptotically efficient rank invariant procedures (with discussion). J Royal Stat Soc Series A 135 (1972) 185-207
12. Donington J.S., Miller D.L., Allen M.S., Deschamps C., Nichols F.C., and Pairolero P.C. Tumor response to induction chemoradiation: influence on survival after esophagectomy. Eur J Cardiothorac Surg 24 (2003) 631-637
13. Donington J.S., Miller D.L., Allen M.S., Deschamps C., Nichols F.C., and Pairolero P.C. Preoperative chemoradiation therapy does not improve early survival after esophagectomy for patients with clinical stage III adenocarcinoma of the esophagus. Ann Thorac Surg 77 (2004) 1193-1199
14. Jatoi A., Martenson J.A., Foster N.R., et al. Paclitaxel, carboplatin, 5-fluorouracil, and radiation for locally advanced esophageal cancer. Am J Clin Oncol 30 (2007) 507-513
15. Miller R.C., Haddock M.G., Gunderson L.L., et al. Intraoperative radiotherapy for treatment of locally advanced and recurrent esophageal and gastric adenocarcinomas. Dis Esophagus 19 (2006) 487-495
16. Walsh T.N., Noonan N., Hollywood D., Kelly A., Keeling N.P., and Hennessy T.P. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335 (1996) 462-467
17. Urba S.G., Orringer M.B., Turrisi A., Iannettoni M., Forastiere A., and Strawderman M. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 19 (2001) 305-313
18. Le Prise E., Etienne P.L., Meunier B., et al. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 73 (1994) 1779-1784
19. Franklin R., Steiger Z., Vaishampayan G., et al. Combined modality therapy for esophageal squamous cell carcinoma. Cancer 51 (1983) 1062-1071
20. Leichman L., Steiger Z., Seydel H.G., et al. Preoperative chemotherapy and radiation therapy for patients with cancer of the esophagus: a potentially curative approach. J Clin Oncol 2 (1984) 75-79
21. Seydel H.G., Leichman L., Byhardt R., et al. Preoperative radiation and chemotherapy for localized squamous cell carcinoma of the esophagus: a RTOG study. Int J Radiat Oncol Biol Phys 14 (1988) 33-35
22. Poplin E., Fleming T., Leichman L., et al. Combined therapies for squamous-cell carcinoma of the esophagus, a Southwest Oncology Study Group (SWOG-8037). J Clin Oncol 5 (1987) 622-628
23. Forastiere A.A., Orringer M.B., Oerez-Tamayo C., Urba S.G., and Zahurak M. Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: final report. J Clin Oncol 11 (1993) 1118-1123
24. Adelstein D.J., Rice T.W., Becker M., et al. Use of concurrent chemotherapy, accelerated fractionation radiation, and surgery for patients with esophageal carcinoma. Cancer 80 (1997) 1011-1020
25. Kesler K.A., Helft P.R., Werner E.A., et al. A retrospective analysis of locally advanced esophageal cancer patients treated with neoadjuvant chemoradiation therapy followed by surgery or surgery alone. Ann Thorac Surg 79 (2005) 1116-1121
26. Rohatgi P., Swisher S.G., Correa A.M., et al. Characterization of pathologic complete response after preoperative chemoradiotherapy in carcinoma of the esophagus and outcome after pathologic complete response. Cancer 104 (2005) 2365-2372
27. Schneider P.M., Baldus S.E., Metzger R., et al. Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiotherapy for esophageal cancer. Implications for response classification. Ann Surg 242 (2005) 684-692
28. Hammoud Z.T., Kesler K.A., Ferguson M.K., et al. Survival outcomes of resected patients who demonstrate a pathologic complete response after neoadjuvant chemoradiation therapy for locally advanced esophageal cancer. Dis Esophagus 19 (2006) 69-72
29. Rizk N.P., Venkatraman E., Bains M.S., et al. American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma. J Clin Oncol 25 (2007) 507-512
30. Swisher S.G., Hofstetter W., Wu T.T., et al. Proposed revision of the esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT). Ann Surg 241 (2005) 810-817
31. Rohatgi P.R., Swisher S.G., Correa A.M., et al. Failure patterns correlate with the proportion of residual carcinoma after preoperative chemoradiotherapy for carcinoma of the esophagus. Cancer 104 (2005) 1349-1355
32. Rizk N.P., Venkatraman E., Park B., et al. The prognostic importance of the number of involved lymph nodes in esophageal cancer; implications for revisions of the American Joint Committee on Cancer Staging System. J Thorac Cardiovasc Surg 132 (2006) 1374-1381
33. Hofstetter W., Correa A.M., Bekele N., et al. Proposed modification of nodal status in AJCC esophageal cancer staging system. Ann Thorac Surg 84 (2007) 365-373
34. Berger A.C., Farma J., Scott W.J., et al. Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival. J Clin Oncol 23 (2005) 4330-4337
35. Lin F.C., Durkin A.E., and Ferguson M.K. Induction therapy does not increase surgical morbidity after esophagectomy for cancer. Ann Thorac Surg 78 (2004) 1783-1789
36. Agarwal B., Swisher S.G., Ajani J., et al. Differential response to preoperative chemoradiation and surgery in esophageal adenocarcinomas based on presence of Barrett's esophagus and symptomatic gastroesophageal reflux. Ann Thorac Surg 79 (2005) 1716-1723
37. Rohatgi P.R., Correa A.M., Swisher S.G., et al. Gender-based analysis of esophageal cancer patients undergoing preoperative chemoradiation: differences in presentation and therapy outcome. Dis Esophagus 19 (2006) 152-157
38. Rohatgi P.R., Swisher S.G., Correa A.M., et al. Histologic subtypes as determinants of outcome in esophageal carcinoma patients with pathologic complete response after preoperative chemoradiotherapy. Cancer 106 (2006) 552-558